Effect of food on the oral bioavailability of sacubitril/valsartan (LCZ696) in healthy subjects


Trial Profile

Effect of food on the oral bioavailability of sacubitril/valsartan (LCZ696) in healthy subjects


Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Sacubitril/valsartan (Primary)
  • Indications Essential hypertension; Heart failure; Hypertension
  • Focus Pharmacokinetics
  • Sponsors Novartis Pharma
  • Most Recent Events

    • 05 Nov 2016 New trial record
    • 10 Oct 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top